The landscape of dementia diagnosis has advanced significantly with the advent of innovative biomarkers, which include amyloid PET scans, tau imaging, and blood-centered checks which can detect Alzheimer's pathology decades before symptoms arise. Though these technological innovations stand for extraordinary development in knowledge neurodegenerati